| 31. | Plasmin is inactivated by proteins such as sterically shielded, thus substantially decreasing the plasmin's access to protein substrates.
|
| 32. | Promatrilysin ( Pro-MMP7 ) is converted from the latent form to the active form by endoproteinases, and plasmin.
|
| 33. | Plasmin is a fibrolytic enzyme that aids in the breakdown of blood clots and is used clinically for that exact purpose.
|
| 34. | Tissue-type plasminogen activator ( tPA ) is a serine proteinase that transforms plasminogen into its activated form, plasmin.
|
| 35. | To be specific, tPA cleaves the zymogen plasminogen at its Arg561-Val562 peptide bond, into the serine protease plasmin.
|
| 36. | Tranexamic and aminocaproic acids inhibit the conversion of plasminogen to plasmin, plasmin being the agent of fibrin breakdown in blood clots.
|
| 37. | Tranexamic and aminocaproic acids inhibit the conversion of plasminogen to plasmin, plasmin being the agent of fibrin breakdown in blood clots.
|
| 38. | It exhibits an anti-plasmin inhibitory effect It also exhibits a cytoprotective effect against oxidative stress in Chinese hamster lung fibroblasts.
|
| 39. | In contrast, plasmin further stimulates plasmin generation by producing more active forms of both tissue plasminogen activator ( tPA ) and urokinase.
|
| 40. | In contrast, plasmin further stimulates plasmin generation by producing more active forms of both tissue plasminogen activator ( tPA ) and urokinase.
|
